Grant opportunity preview
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Offered by National Institutes of Health
HealthcareNationalJuly 2, 2027
Opportunity summary
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompa…
Sign in to review full eligibility requirements, application details, matching insights, and verified source links.